Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Suzuki, K."'
Autor:
Facon T; Department of Hematology, Lille University Hospital, Lille, France., Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Špicka I; Department of Hematology, 1st Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Suzuki K; Myeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan., Yong K; Department of Haematology, University College Hospital, London, UK., Mikhael J; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, USA., Fukao T; Sanofi, Global Oncology, Cambridge, Massachusetts, USA., Bisht K; Sanofi, Global Oncology, Cambridge, Massachusetts, USA., Armstrong NM; Sanofi, Global Medical Affairs, Cambridge, Massachusetts, USA., Macé S; Sanofi, Research and Development, Chilly-Mazarin, France., Risse ML; Sanofi, Research and Development, Vitry-Sur-Seine, France., Martin T; University of California San Francisco Medical Center, San Francisco, California, USA.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 Mar; Vol. 42 (2), pp. e3258.
Autor:
Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia., Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France., Mateos MV; University Hospital of Salamanca/Instituto de Investigación Biomédica de Salamanca/Centre for Cancer Research Institute of Cancer Molecular and Cellular Biology, Salamanca, Spain., Goldschmidt H; University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases, Heidelberg, Germany., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Levin MD; Albert Schweitzer Hospital, Dordrecht, The Netherlands., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Reece D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Ahmadi T; Genmab US, Inc, Plainsboro, NJ., Pei H; Janssen Research & Development, LLC, Titusville, NJ., Mayo WG; Janssen Research & Development, LLC, Raritan, NJ., Gai X; Janssen Research & Development, LLC, Beijing, China., Carey J; Janssen Research & Development, LLC, Spring House, PA., Bartlett JB; Janssen Research & Development, LLC, Raritan, NJ., Carson R; Janssen Research & Development, LLC, Spring House, PA., Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Blood advances [Blood Adv] 2024 Jan 23; Vol. 8 (2), pp. 388-398.
Autor:
Suzuki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan. kaz-suzuki@jikei.ac.jp., Gunji T; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Daisan Hospital, Komoe, Japan., Kawashima M; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan., Uryu H; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Daisan Hospital, Komoe, Japan., Nagao R; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Momoki M; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Yokoyama H; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan., Ishii H; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Tanoue S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan., Saito T; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan., Nishiwaki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Yano S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.
Publikováno v:
International journal of hematology [Int J Hematol] 2024 Jan; Vol. 119 (1), pp. 39-49. Date of Electronic Publication: 2023 Dec 16.
Autor:
Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Kunisada K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Yogo M; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Oda Y; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Sato K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Takei T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Ogura M; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Abe Y; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3248.
Autor:
Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan. taku_k_1123@mac.com., Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Kunisada K; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Nomura-Yogo M; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Oda Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Sato K; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Takei T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Ogura M; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Abe Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Dec; Vol. 102 (12), pp. 3489-3497. Date of Electronic Publication: 2023 Sep 05.
Autor:
Suzuki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan. Electronic address: kaz-suzuki@jikei.ac.jp., Shimazu Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Minakata D; Division of Hematology, Jichi Medical University, Tochigi, Japan., Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan., Takahashi H; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Kanagawa, Japan., Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Kanda Y; Division of Hematology, Jichi Medical University, Tochigi, Japan; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Nishiwaki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan., Miwa A; Department of Hematology, Tokyo-Kita Medical Center, Tokyo, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Aichi, Japan., Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan., Itagaki M; Department of Hematology, Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital, Hiroshima, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan., Yano S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Kawamura K; Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Nov; Vol. 29 (11), pp. 688.e1-688.e13. Date of Electronic Publication: 2023 Aug 11.
Autor:
Kawano Y; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan. Electronic address: yawara.kawano@gmail.com., Kim K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Min CK; Department of Hematology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Ishizawa K; Department of Hematology and Cell Therapy, Yamagata University, Yamagata, Japan., Kim SH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Ito S; Division of Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan., Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan., Uchiyama M; Department of Hematology, Japanese Red Cross Society, Suwa Hospital, Suwa, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Kim JS; Department of Hematology, Severance Hospital, Seoul, Republic of Korea., Moreau P; Department of Hematology, University Hospital of Nantes, Nantes, France., Martin T; Department of Medicine, University of California, San Francisco, CA., Tada K; Research and Development, Sanofi K.K., Tokyo, Japan., Risse ML; Sanofi Research and Development, Vitry-sur-Seine, France., Suzuki K; Myeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Oct; Vol. 23 (10), pp. e360-e367. Date of Electronic Publication: 2023 Jul 03.
Autor:
Abe Y; Division of Haematology, Japanese Red Cross Medical Centre, 4 Chome-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan., Sasaki M; Division of Haematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan., Takezako N; Division of Haematology, Japan Association for Development of Community Medicine, Nerima Hikarigaoka Hospital, Tokyo, Japan., Ito S; Division of Haematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan., Suzuki K; Division of Clinical Oncology and Haematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan., Handa H; Department of Haematology, Gunma University Graduate School of Medicine, Gunma, Japan., Chou T; Niigata Kenshin Plaza, General Incorporated Foundation, Health Medicine Prevention Association, Niigata, Japan., Yoshida T; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan., Mori I; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan., Shinozaki T; Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan., Suzuki K; Division of Haematology, Japanese Red Cross Medical Centre, 4 Chome-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan. ken-suzuki@mtb.biglobe.ne.jp.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Sep; Vol. 102 (9), pp. 2493-2504. Date of Electronic Publication: 2023 Jun 21.
Autor:
Sunami K; Department of Hematology, National Hospital Organization, Okayama Medical Center, Okayama, Japan., Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Suzuki K; Myeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan., Ri M; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan., Matsumoto M; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan., Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Asaoku H; Hiroshima Red Cross Blood Center, Hiroshima, Japan., Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Ishizawa K; Department of Third Internal Medicine, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan., Takamatsu H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan., Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan., Uchiyama M; Department of Hematology, Japanese Red Cross Society Suwa Hospital, Suwa, Japan., Kiguchi T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan.; Division of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan., Iyama S; Department of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan., Murakami H; Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan., Onishi R; Sanofi, Research and Development, Tokyo, Japan., Tada K; Sanofi, Research and Development, Tokyo, Japan., Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Publikováno v:
Hematological oncology [Hematol Oncol] 2023 Aug; Vol. 41 (3), pp. 442-452. Date of Electronic Publication: 2022 Dec 15.
Autor:
Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan. taku_k_1123@mac.com., Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Nomura M; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Kasuya Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Oda Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Sato K; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Takei T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Ogura M; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Abe Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, 4-chōme-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Jun; Vol. 102 (6), pp. 1477-1483. Date of Electronic Publication: 2023 Apr 28.